Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Aged mice (12 months, roughly equivalent to middle age in humans) administered MOTS-c for four weeks showed improved physical performance, grip strength, and metabolic markers compared to controls
Lynch R, Diggins EL, Connors SL, Zimmerman AW, Singh K, Liu H, et al
Research shows these peptides are well-tolerated, with minimal reported side effects when used responsibly and under guidance.
TB-500 is currently understood by FDA and WADA research as the N-terminally acetylated seven-residue thymosin beta-4 fragment Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln
Eslami, S
& Martin, S
US$ 20.99
US$ 29.39
US$ 23.18
US$ 21.53
US$ 24.40
